Analysis of the sensitivity of in vitro bioassays for androgenic, progestagenic, glucocorticoid, thyroid and estrogenic activity: Suitability for drinking and environmental waters.
Citations
167 citations
87 citations
Cites background from "Analysis of the sensitivity of in v..."
...Estrogenic activity in wastewater effluent will vary depending on the treatment processes and wastewater type (Maletz et al., 2013; Valitalo et al., 2016), with surface waters downstream of wastewater discharges often having elevated estrogenicity (Schiliro et al., 2009; Mnif et al., 2012)....
[...]
...Estrogenic activity in wastewater effluent will vary depending on the treatment processes and wastewater type (Maletz et al., 2013; Valitalo et al., 2016), with surface waters downstream of wastewater discharges often having elevated estrogenicity (Schiliro et al....
[...]
66 citations
64 citations
64 citations
References
1,192 citations
"Analysis of the sensitivity of in v..." refers background in this paper
...In addition to natural and synthetic hormones, awide range of environmental chemicals, including industrial compounds, pesticides and UV filters, have been identified as known or suspected endocrine disrupting chemicals (Bergman et al., 2012)....
[...]
842 citations
"Analysis of the sensitivity of in v..." refers background or methods in this paper
...Receptor binding assays, including the classical (Leusch et al., 2006) and recombinant androgen receptor binding assay (Freyberger and Ahr, 2004), and yeast reporter gene assays, including the classical yeast androgen screen (YAS) (Gaido et al., 1997; Sohoni and Sumpter, 1998) and two-hybrid assay (Li et al., 2008a) had similar MDLs in agonist mode, which ranged from 8.3–26 ng/L (Table 1)....
[...]
...…receptor binding assay (Leusch et al., 2006) and the yeast reporter gene assays, yeast estrogen screen (YES) originally from John Sumpter's lab (Sohoni and Sumpter, 1998) and from Kevin Gaido's lab (Gaido et al., 1997), respectively, had similar MDLs, ranging from 1.2–1.8 ng/L. Re-analysis of…...
[...]
...0 amiodarone hydrochloride equivalents; DF, dilution factor; DHT, dihydrotestosterone; DHTEQ, dihydrotestosterone equivalents; ; Dexa, dexamethasone; DexaEQ, dexamethasone equivalents; E2, 17β-estradiol; EEQ, 17β-estradiol equivalents; EC, effect EQ, flutamide equivalents; FulvestrantEQ, fulvestrant equivalents; Levo, levonorgestrel; LevoEQ, levonorgestrel equivalents; valents; OHFLU, hydroxyflutamide; OHFLUEQ, hydroxyflutamide equivalents; OHTMX, hydroxytamoxifen; ORG2058, 16αrogesterone; P4EQ, progesterone equivalents; PMG, promegestone; PMGEQ, promegestone equivalents; REP, relative effect tion; T3, triiodothyronine; T3EQ, triiodothyronine equivalents; TMX, tamoxifen; TMXEQ, tamoxifen equivalents; YAS, yeast )....
[...]
..., 2006) and the yeast reporter gene assays, yeast estrogen screen (YES) originally from John Sumpter's lab (Sohoni and Sumpter, 1998) and from Kevin Gaido's lab (Gaido et al....
[...]
...…equivalents, the higher tolerance of yeast-based assays to solvents (up to 1%, compared to 0.1% for most mammalian assays) meant that the MDL for the most sensitive yeast assay (Sohoni and Sumpter, 1998) was comparable (although in the upper range) to the mammalian reporter gene assays....
[...]
735 citations
"Analysis of the sensitivity of in v..." refers methods in this paper
...As mentioned above, the GeneBLAzer assays produce enzyme beta-lactamase in the presence of agonists and beta-lactamase cleaves the fluorescent substrate to increase blue fluorescence (Zlokarnik et al., 1998)....
[...]
662 citations
"Analysis of the sensitivity of in v..." refers background or methods in this paper
...Receptor binding assays, including the classical (Leusch et al., 2006) and recombinant androgen receptor binding assay (Freyberger and Ahr, 2004), and yeast reporter gene assays, including the classical yeast androgen screen (YAS) (Gaido et al., 1997; Sohoni and Sumpter, 1998) and two-hybrid assay (Li et al., 2008a) had similar MDLs in agonist mode, which ranged from 8.3–26 ng/L (Table 1)....
[...]
...0 amiodarone hydrochloride equivalents; DF, dilution factor; DHT, dihydrotestosterone; DHTEQ, dihydrotestosterone equivalents; ; Dexa, dexamethasone; DexaEQ, dexamethasone equivalents; E2, 17β-estradiol; EEQ, 17β-estradiol equivalents; EC, effect EQ, flutamide equivalents; FulvestrantEQ, fulvestrant equivalents; Levo, levonorgestrel; LevoEQ, levonorgestrel equivalents; valents; OHFLU, hydroxyflutamide; OHFLUEQ, hydroxyflutamide equivalents; OHTMX, hydroxytamoxifen; ORG2058, 16αrogesterone; P4EQ, progesterone equivalents; PMG, promegestone; PMGEQ, promegestone equivalents; REP, relative effect tion; T3, triiodothyronine; T3EQ, triiodothyronine equivalents; TMX, tamoxifen; TMXEQ, tamoxifen equivalents; YAS, yeast )....
[...]
...Environment International xxx (2016) xxx–xxx EI-03541; No of Pages 11 Contents lists available at ScienceDirect Environment International j ourna l homepage: www.e lsev ie r .com/ locate /env int Review article Analysis of the sensitivity of in vitro bioassays for androgenic, progestagenic, glucocorticoid, thyroid and estrogenic activity: Suitability for drinking and environmental waters Frederic D.L. Leusch a,⁎, Peta A. Neale a, Armelle Hebert b, Marco Scheurer c, Merijn C.M. Schriks d a Australian Rivers Institute, Griffith School of Environment, Griffith University, Gold Coast, Qld, 4222, Australia b Veolia Research & Innovation, Paris, France c DVGW – TechnologiezentrumWasser, Karlsruhe, Germany d KWR Watercycle Research Institute, Nieuwegein, The Netherlands Abbreviations:AH, amiodarone hydrochloride; AHEQ, DOC, dissolved organic carbon; DPH, diphenylhydantoin concentration; EF, enrichment factor; FLU, flutamide; FLU MDL, method detection limit; MifEQ, mifepristone equi ethyl-21-hydroxy-19-nor-pregn-4-ene-3,20-dione; P4, p potency; RU5020, promegestone; SPE, solid phase extrac androgen screen; YES, yeast estrogen screen....
[...]
..., 1997) as these assays cannot distinguish between agonists and antagonists, with the pure agonist ICI 164,384 producing an estrogenic response in the YES assay (Gaido et al., 1997)....
[...]
...…yeast reporter gene assays, yeast estrogen screen (YES) originally from John Sumpter's lab (Sohoni and Sumpter, 1998) and from Kevin Gaido's lab (Gaido et al., 1997), respectively, had similar MDLs, ranging from 1.2–1.8 ng/L. Re-analysis of E2 concentration-effect curves for ERCALUX (Sonneveld…...
[...]
529 citations